Europe — EMA
Octanate (Human Coagulation Factor Viii)
Human Coagulation Factor VIII, the active ingredient in Octanate, is a coagulation factor replacement therapy presented as a sterile solution for intravenous use.
Request sourcing
What is Human Coagulation Factor Viii?
Human Coagulation Factor VIII, the active ingredient in Octanate, is a coagulation factor replacement therapy presented as a sterile solution for intravenous use. It treats hemophilia A and related bleeding disorders in patients requiring factor VIII supplementation. GNH USA supplies Octanate as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
GNH USA supplies Octanate as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
What is Human Coagulation Factor Viii used for?
Octanate is used in the management of bleeding disorders that involve the intrinsic coagulation pathway, particularly hemophilia A.
- Hemophilia A (severe or moderate): Provides factor VIII replacement to control and prevent bleeding episodes. - Hemophilia A (mild): Increases the circulating level of factor VIII to reduce spont the risk of spontaneous bleeding. - Acquired A - - t
